Apollomics logo

Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and combination cancer therapies.

26 employees · est. 2015 · Foster City, United States

VS
Cornerstone Pharmaceuticals logo

Cornerstone Pharmaceuticals

Rare Science. Rare Compassion. Rare Solutions.

11 employees · est. 2001 · Cranbury, United States

Cornerstone Pharmaceuticals is the older company (2015 vs 2001).

Side-by-Side Comparison

Apollomics Cornerstone Pharmaceuticals
Founded
2015 2001 older
Headquarters
Foster City, United States Cranbury, United States
Employees
26 11
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Pharmaceutical
Funding Stage
Post Ipo Equity Not tracked yet
Total Funding
$262.60M Not tracked yet
Funding Rounds
5 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical Company, Oncology Therapies, Combination Therapies, Cancer Treatment, Drug Development, Immune System, Molecular Pathways, Clinical Trials, Immunotherapy, Monoclonal Antibodies, Targeted Therapies, Cancer Research, Drug Candidates, Pharmaceutical Pipeline Metabolic Oncology, Therapeutics, Cancer Treatment, Drug Development, Clinical-stage Company, Bio-energetic Processes, Altered Cancer Metabolism, Novel Drugs, Drug Delivery Technologies, Anti-cancer Agents, Clinical Studies, Mitochondria Targeting, Rare Cancers, Devimistat, Mitochondrial Disruption
Website
apollomicsinc.com cornerstonepharma.com
Apollomics logo

About Apollomics

Apollomics is a biopharmaceutical company with a clear mission to discover and develop mono- and combination cancer therapies. Established in 2016, Apollomics has made strategic moves to operate in both the U.S. and China, aiming to harness synergies by collaborating with biotechnology companies in...

Cornerstone Pharmaceuticals logo

About Cornerstone Pharmaceuticals

Cornerstone Pharmaceuticals is a clinical-stage biotechnology startup that focuses on developing metabolic oncology therapeutics for hard-to-treat cancers. The company's slogan "Rare Science. Rare Compassion. Rare Solutions." emphasizes its dedication to addressing the unique needs of patients with...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Apollomics and Cornerstone Pharmaceuticals — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Apollomics and Cornerstone Pharmaceut... — by email.

Frequently Asked Questions

Apollomics — We are a biopharmaceutical company committed to the discovery and development of mono- and combination cancer therapies.. Cornerstone Pharmaceuticals — Rare Science. Rare Compassion. Rare Solutions.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Apollomics has raised $262.60M while Cornerstone Pharmaceuticals has raised undisclosed funding.
Apollomics and Cornerstone Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Apollomics with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy